Welcome to our dedicated page for Docebo SEC filings (Ticker: DCBO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Docebo Inc. (DCBO) filings with the U.S. Securities and Exchange Commission, along with AI-powered tools that help explain the information contained in those documents. As a foreign issuer that files under Form 40-F, Docebo submits Form 6-K reports that include unaudited condensed consolidated interim financial statements, management’s discussion and analysis, and press releases summarizing quarterly results.
In these filings, Docebo discloses details about its subscription and professional services revenue, total revenue, gross profit, net income, and non-IFRS measures such as Adjusted EBITDA, Adjusted Net Income, Annual Recurring Revenue (ARR), Average Contract Value, Free Cash Flow, and working capital. Exhibits to the Form 6-K often incorporate financial statements and certifications by reference into existing registration statements, reflecting the company’s status as a cross-listed issuer on NASDAQ and the Toronto Stock Exchange.
Through this filings page, you can review Docebo’s periodic financial updates, key performance indicators, and narrative discussion of its AI-first learning platform strategy and business outlook. Real-time integration with EDGAR ensures that new Form 6-K submissions and related documents are available as they are filed. AI-generated summaries highlight the main points in lengthy filings, helping you quickly understand revenue trends, profitability metrics, and other information that may be relevant to analysis of DCBO.
In addition to financial data, Docebo’s filings may reference matters such as its normal course issuer bid, credit facilities, risk factors, and other disclosures required under Canadian and U.S. securities regulations. This page centralizes those SEC documents so that investors and researchers can efficiently review the company’s regulatory history and ongoing reporting.
Docebo Inc. received an ownership update from major shareholder Intercap Inc. and its founder Jason Chapnik. Docebo ran a substantial issuer bid that expired on March 10, 2026, under which Intercap was expected to have 372,612 common shares repurchased at US$20.40 per share, for US$7,601,284.80 in cash.
After this transaction, Chapnik is deemed to beneficially own 15,945,759 common shares, or 61.7% of the company, including 32,407 shares issuable from vested deferred share units. Intercap beneficially owns 15,913,352 common shares, or 61.6%, based on 25,819,890 shares outstanding upon expiration of the offer, so they remain controlling shareholders.
Docebo Inc. reported the preliminary results of its substantial issuer bid to repurchase common shares. The company expects to buy for cancellation 2,941,176 Common Shares at US$20.40 per share, for aggregate consideration of US$60,000,000.
The shares expected to be purchased represent approximately 10.2% of issued and outstanding Common Shares on a non-diluted basis as of February 1, 2026. After the transaction, approximately 25,819,890 Common Shares are expected to be issued and outstanding.
The offer was oversubscribed, with shareholders (other than odd-lot holders) expected to have about 74.52% of their successfully tendered shares purchased. Intercap Inc. is expected to have 372,612 shares acquired under the offer and to beneficially own 15,913,352 shares, or about 61.6% of the company, following completion.
Docebo Inc. reported strong Q4 and full-year 2025 results and confirmed a sizable share repurchase offer. Q4 revenue was $63.0M, up 10.5%, with subscription revenue of $59.1M up 9.5% and representing 94% of total revenue. Net income jumped to $26.9M from $11.9M, while Adjusted EBITDA rose to $13.3M with a 21.2% margin. ARR reached $238.1M, up 8.4%, and the largest OEM customer declined to 4.4% of ARR from 9.5%.
For 2025, revenue was $242.7M, up 11.9%, with net income of $37.5M and Adjusted EBITDA of $43.9M, up 30.6%. The company reaffirmed its AI-first, multi-product strategy and highlighted several large enterprise and public-sector wins. Docebo waived the share price condition on its substantial issuer bid to repurchase up to $60M of shares at $20.40, with expiry on March 10, 2026. Guidance for 2026 calls for total revenue of $267.5M–$269.5M and Adjusted EBITDA of $52.5M–$54.5M.
Docebo Inc. files its Annual Report on Form 40-F, providing audited financial statements and governance disclosures for the fiscal year ended December 31, 2025. The filing incorporates the Annual Information Form, audited consolidated financial statements and MD&A as Exhibits 99.1, 99.2 and 99.3, and includes KPMG LLP’s attestation on internal control over financial reporting.
The company reports 28,747,289 common shares outstanding as of December 31, 2025, describes applicable Nasdaq/TSX governance elections, and files executive certifications and related exhibits dated February 27, 2026.
Docebo Inc. is moving ahead with a substantial issuer bid to repurchase for cancellation up to US$60,000,000 of its common shares at US$20.40 per share. This transaction lets shareholders sell shares back to the company at a fixed premium-style price.
Major shareholder Intercap Equity Inc., which beneficially owns about 56.6% of Docebo’s outstanding common shares (including a committed acquisition from WPGG 14 Investment Ltd. IV), now indicates it may tender shares in order to maintain its approximate ownership level. Docebo’s board continues to back the bid, stating the current trading price does not fully reflect the company’s value and future prospects.
To finance the repurchase, Docebo plans to use roughly US$30,000,000 of cash on hand and draw about US$30,000,000 from its credit facility. The company has amended and restated its credit agreement, increasing the secured revolving facility by US$50,000,000 to a total of US$100,000,000, with a three-year term and variable interest rates based on financial ratios. The facility can be expanded by up to an additional US$50,000,000 and can also support general corporate purposes, acquisitions and investments.
The offer is scheduled to expire on March 10, 2026, unless it is extended, varied or withdrawn. Shareholders holding through brokers or other nominees are encouraged to work through those intermediaries if they wish to tender shares into the bid.
Docebo Inc. Schedule 13G/A amendment: affiliated Warburg Pincus entities state they will sell all previously reported Common Shares, with that sale expected to close on 02/27/2026. The Reporting Persons say the November 27, 2025 Agreement of Purchase and Sale ceased to be subject to material closing conditions on 02/09/2026, and this Statement is a voluntary filing.
Intercap Inc., Intercap Equity Inc., and Jason Chapnik report a controlling stake in Docebo Inc. through a Schedule 13D filing. They beneficially own 16,318,371 common shares, representing 56.7% of Docebo’s 28,757,629 common shares outstanding as of February 1, 2026. A share purchase agreement dated November 27, 2025 provides for Intercap to acquire 3,630,715 shares from WPGG 14 Investment Ltd. IV at $18.77 per share, for a total of $68,148,520.55, with closing expected on or about February 27, 2026, subject to customary conditions. An investor rights agreement grants Intercap-related entities significant board nomination, registration and pre‑emptive rights, and following completion of the purchase they will be entitled to nominate a majority of Docebo’s directors.
Docebo Inc. has formally commenced a substantial issuer bid to repurchase for cancellation up to 2,941,176 of its outstanding common shares. The company is offering US$20.40 per share, with the total amount of shares bought back capped at an aggregate price of up to US$60,000,000.
The offer begins on February 3, 2026 and is scheduled to expire on March 10, 2026, unless it is extended, varied or withdrawn. Full details are provided in the offer documents filed on SEDAR+ and EDGAR, which have been mailed to shareholders. Docebo emphasizes that investors should carefully review these documents before deciding whether to tender shares.
Docebo Inc. has launched a substantial issuer bid to repurchase for cancellation up to US$60,000,000 of its common shares at US$20.40 per share, representing approximately 10.23% of its issued and outstanding shares on a non‑diluted basis.
The company plans to fund the offer with about US$30,000,000 of cash on hand and an approximately US$30,000,000 draw on its credit facility, which it is seeking to increase from US$50,000,000 to US$100,000,000, subject to lender approval. Majority shareholder Intercap Equity Inc., which holds about 56.6% of the shares, does not intend to participate. Docebo has also released preliminary, unaudited fourth quarter 2025 results and provided financial guidance for 2026, and has suspended repurchases under its normal course issuer bid while the offer is outstanding.
Docebo Inc. filed a Form 6-K as a foreign private issuer to furnish its latest interim information to U.S. investors. The report packages unaudited condensed consolidated interim financial statements and management’s discussion and analysis for the three and nine months ended September 30, 2025, giving a detailed view of the company’s third-quarter 2025 performance and financial condition.
The filing also includes a press release titled “Docebo Reports Third Quarter 2025 Results,” CEO and CFO interim filing certificates under Canadian regulations, and full Inline XBRL data files for electronic analysis. Together, these materials provide a comprehensive update on Docebo’s Q3 2025 operations, governance sign-offs, and structured financial disclosures.